Yosuke Kito
Yosuke Kito publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Surgery, on topics such as Gastric Cancer Management and Outcomes, Colorectal Cancer Treatments and Studies and Cancer Immunotherapy and Biomarkers.
- World rank
- #3,619,786 of 7,710,434 ranked researchers
- Rank in Japan
- #90,687 of 383,136
- Works
- 101
- Citations
- 709
- Citations per work
- 7.0
What does Yosuke Kito research?
Yosuke Kito's work is mostly in Medicine (82%), Biochemistry, Genetics and Molecular Biology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences8382.5%
- Medicine8382.5%
- Everything else1413.7%
- Life Sciences43.8%
- 1Oncology33% of their works
- 2Pulmonary and Respiratory Medicine28% of their works
- 3Surgery16% of their works
- 4Cancer Research4% of their works
- 5Gastroenterology3% of their works
- 6Otorhinolaryngology2% of their works
Research topics
- Gastric Cancer Management and Outcomes
- Colorectal Cancer Treatments and Studies
- Cancer Immunotherapy and Biomarkers
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Esophageal Cancer Research and Treatment
- Cancer Genomics and Diagnostics
- Cancer Treatment and Pharmacology
- Lung Cancer Treatments and Mutations
Which keywords describe Yosuke Kito's research?
The keywords of their largest research topics: Chemotherapy, Endoscopic Resection, Gastric Cancer, Molecular Characterization, Cetuximab, KRAS Mutations, Epidemiology and Immune Checkpoint Blockade.
- EGFR Mutations
- Taxanes
- Chemotherapy-Induced Peripheral Neuropathy
- Preoperative Chemoradiotherapy
- Cholangiocarcinoma
- Targeted Therapy
- Immune Checkpoint Blockade
- KRAS Mutations
- Molecular Characterization
- Endoscopic Resection
- Chemotherapy
- Gastric Cancer
- Cetuximab
- Epidemiology
- PD-1 and PD-L1
- Biliary Tract Cancer
- Esophageal Carcinoma
- Cancer Genomics
- Mutational Signatures
- ALK Inhibitors
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 20 words, with their numbers
- Chemotherapy942 topics
- Endoscopic Resection662 topics
- Gastric Cancer541 topic
- Molecular Characterization541 topic
- Cetuximab401 topic
- KRAS Mutations401 topic
- Epidemiology272 topics
- Immune Checkpoint Blockade211 topic
- PD-1 and PD-L1211 topic
- Targeted Therapy202 topics
- Biliary Tract Cancer151 topic
- Cholangiocarcinoma151 topic
- Esophageal Carcinoma121 topic
- Preoperative Chemoradiotherapy121 topic
- Cancer Genomics111 topic
- Chemotherapy-Induced Peripheral Neuropathy111 topic
- Mutational Signatures111 topic
- Taxanes111 topic
- ALK Inhibitors91 topic
- EGFR Mutations91 topic
Where does Yosuke Kito work?
Yosuke Kito's main affiliation in the publication record is Ishikawa Prefectural Central Hospital, Japan.
How many publications and citations does Yosuke Kito have?
OpenAlex counts 101 works and 709 citations for Yosuke Kito, an h-index of 14, ranking #3,619,786 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Yosuke Kito
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Yosuke Kito. Posts are plain text and can be reported.